Cargando…
Clusterin Is Required for β-Amyloid Toxicity in Human iPSC-Derived Neurons
Our understanding of the molecular processes underlying Alzheimer’s disease (AD) is still limited, hindering the development of effective treatments, and highlighting the need for human-specific models. Advances in identifying components of the amyloid cascade are progressing, including the role of...
Autores principales: | Robbins, Jacqueline P., Perfect, Leo, Ribe, Elena M., Maresca, Marcello, Dangla-Valls, Adrià, Foster, Evangeline M., Killick, Richard, Nowosiad, Paulina, Reid, Matthew J., Polit, Lucia Dutan, Nevado, Alejo J., Ebner, Daniel, Bohlooly-Y, Mohammad, Buckley, Noel, Pangalos, Menelas N., Price, Jack, Lovestone, Simon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6068261/ https://www.ncbi.nlm.nih.gov/pubmed/30090055 http://dx.doi.org/10.3389/fnins.2018.00504 |
Ejemplares similares
-
Glycosylated clusterin species facilitate Aβ toxicity in human neurons
por: Foster, Evangeline M., et al.
Publicado: (2022) -
Clusterin in Alzheimer’s Disease: Mechanisms, Genetics, and Lessons From Other Pathologies
por: Foster, Evangeline M., et al.
Publicado: (2019) -
Interferon-γ exposure of human iPSC-derived neurons alters major histocompatibility complex I and synapsin protein expression
por: Pavlinek, Adam, et al.
Publicado: (2022) -
Apolipoprotein E expression pattern in human induced pluripotent stem cells during
in vitro neural induction
por: Lee, Hyunah, et al.
Publicado: (2020) -
Banking on iPSC- Is it Doable and is it Worthwhile
por: Solomon, Susan, et al.
Publicado: (2014)